Results
151
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
151 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KULR | US$1.89 | -11.3% | 1,320.0% | US$404.6m | US$4.22 | PS41.7x | E78.9% | n/a | Capital Goods | ||
CMPX | US$2.92 | -13.6% | 63.1% | US$401.8m | US$11.22 | PS472.7x | E54.3% | n/a | Pharmaceuticals & Biotech | ||
TKNO | US$7.45 | -10.0% | 115.9% | US$397.1m | US$10.67 | PS10.9x | E22.8% | n/a | Pharmaceuticals & Biotech | ||
AKBA New | US$1.80 | -15.5% | 33.3% | US$392.7m | US$7.17 | PS2.3x | E56.3% | n/a | Pharmaceuticals & Biotech | ||
ETON New | US$14.51 | -11.6% | 224.6% | US$374.9m | US$25.67 | PS10.8x | E46.8% | n/a | Pharmaceuticals & Biotech | ||
HYLN New | US$1.90 | -10.4% | 39.7% | US$330.1m | US$2.00 | PB1.3x | S249.2% | n/a | Capital Goods | ||
HRTG New | US$11.08 | -12.5% | 55.4% | US$322.8m | US$16.00 | PE4.5x | E2.7% | 0% | Insurance | ||
NUTX New | US$57.60 | -12.8% | 226.3% | US$313.2m | US$63.67 | PS1.1x | E121.2% | n/a | Healthcare | ||
BARK New | US$1.74 | -11.7% | 48.7% | US$304.4m | US$3.00 | PS0.6x | E59.3% | n/a | Retail | ||
EHTH New | US$10.05 | -9.8% | 47.1% | US$297.8m | US$8.63 | PS0.6x | E77.8% | n/a | Insurance | ||
EXFY New | US$3.26 | -15.1% | 76.2% | US$290.0m | US$3.50 | PS2.1x | E74.0% | n/a | Software | ||
ALLT | US$6.77 | -9.1% | 260.1% | US$257.8m | US$13.00 | PS2.8x | E61.5% | n/a | Software | ||
FLXS New | US$46.29 | -10.4% | 37.1% | US$243.9m | US$61.00 | PE12.2x | E6.0% | 1.5% | Consumer Durables | ||
FTK New | US$8.22 | -8.9% | 174.0% | US$242.9m | US$8.67 | PE29.7x | E34.5% | n/a | Materials | ||
ELMD New | US$27.97 | -12.3% | 86.7% | US$239.3m | US$37.00 | PE35.4x | E18.2% | n/a | Healthcare | ||
MAMA New | US$6.29 | -13.5% | 30.8% | US$236.4m | US$11.00 | PE67.2x | E54.4% | n/a | Food, Beverage & Tobacco | ||
CDTX New | US$21.54 | -10.0% | 53.9% | US$235.6m | US$31.50 | PS5.3x | E4.4% | n/a | Pharmaceuticals & Biotech | ||
BSEM | US$13.80 | -10.5% | 59.5% | US$229.8m | US$32.50 | PE14.5x | E33.8% | n/a | Pharmaceuticals & Biotech | ||
LFVN | US$16.69 | -10.1% | 148.0% | US$209.5m | US$32.50 | PE28.5x | E34.1% | 1.0% | Household | ||
TZOO | US$17.01 | -19.8% | 84.5% | US$200.8m | US$27.00 | PE14.8x | E26.7% | n/a | Media | ||
XNET New | US$3.13 | -11.8% | 110.1% | US$198.4m | n/a | PE13.8x | n/a | n/a | Software | ||
AEYE New | US$15.21 | -11.8% | 141.4% | US$185.2m | US$32.70 | PS5.6x | E121.5% | n/a | Software | ||
PLX New | US$2.39 | -11.2% | 64.8% | US$176.0m | US$14.50 | PS3.9x | E123.8% | n/a | Pharmaceuticals & Biotech | ||
RAIL | US$8.76 | -21.6% | 182.4% | US$165.4m | US$14.38 | PS0.3x | E60.8% | 0% | Capital Goods |